N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N-methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine
|
|
|
- CAS-Nr.
- 2459302-87-3
- Englisch Name:
- N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N-methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine
- Synonyma:
- Tofatinib impurity 36;Tofacitinib Impurity 173;Azilsartan medoxomil impurity324;N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N-methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine;N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N- methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine;[4,7'-Bi-7H-pyrrolo[2,3-d]pyrimidin]-4'-amine, 2,2'-dichloro-N-methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-
- CBNumber:
- CB83956382
- Summenformel:
- C26H26Cl2N8
- Molgewicht:
- 521.44
- MOL-Datei:
- 2459302-87-3.mol
|
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N-methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine Eigenschaften
- Dichte
- 1.48±0.1 g/cm3(Predicted)
- pka
- 9.16±0.50(Predicted)
Sicherheit
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N-methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine Chemische Eigenschaften,Einsatz,Produktion Methoden
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N-methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N-methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 19)Lieferanten
- N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N-methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine
- Azilsartan medoxomil impurity324
- [4,7'-Bi-7H-pyrrolo[2,3-d]pyrimidin]-4'-amine, 2,2'-dichloro-N-methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-
- Tofacitinib Impurity 173
- N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N- methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine
- Tofatinib impurity 36
- 2459302-87-3
